ICD, Pacemaker Failure Rates Essential To Replacement Decision – JAMA
This article was originally published in The Gray Sheet
Executive Summary
The failure rate for a device under advisory is the most important criterion physicians and patients should take into account when deciding whether to replace an implantable cardioverter defibrillator or pacemaker, according to an article in the July 26 Journal of the American Medical Association.
You may also be interested in...
HRS Ideas Could Spread To Other Devices, FDA Says; MDR Program Debated
Recent draft recommendations from the Heart Rhythm Society to standardize communications on pacemaker and ICD malfunctions could eventually affect all firms regardless of the products they manufacture, an FDA official says
Heart Rhythm Society Calls On Industry, FDA To Overhaul Device Surveillance
Draft recommendations from the Heart Rhythm Society would increase the clarity and amount of information industry gives FDA, physicians and patients on pacemaker and implantable cardioverter defibrillator (ICD) performance
Doctors Discuss Strategies For Responding To Recent Medtronic ICD Recall
Physicians are using Medtronic'sCareLink remote patient monitoring network to closely follow patients implanted with potentially defective ICDs for the primary prevention of sudden cardiac death